On October 15, Britain’s drug regulator added a boxed warning on suicidal thoughts to antidepressant leaflets and the term PSSD to 10 of them. The Daily Mail ran one woman’s account ending in “You must think before taking these drugs”. Read the headline as a sentence. Its subject is the drug, “Antidepressants ruined my sex life”, then come the years, then her regret, then an order to you. Every clause is one woman’s experience, and the last turns it into an instruction for everyone on these pills. One person’s words stand in for the news, and they ride a common habit of the mind: one vivid case stands in for how often it happens. The headline gives no rate, and neither does the page. The page against its headline: the regulator’s change first appears around the 17th paragraph, and “Experts stress that PSSD remains a rare condition” comes more than 50 paragraphs down. The same paper’s news report, posted at 5:34 AM ET, said “can trigger” and named “drug watchdogs”. The feature, at 7:16 AM ET, said “ruined” and “You must”. The MHRA tells patients these are not new risks: SSRI product information has noted long-lasting sexual dysfunction after stopping since 2019. None of this makes her account less real. The regulator acted after concerns from patients and families, and its own words say sexual dysfunction “may continue even after you stop the medicine”. What the headline leaves out is the other half of the advice: do not stop without speaking to a professional, because stopping can bring withdrawal reactions. The tell is the “you” with no number behind it: a warning addressed to every reader, built on one case.
